Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Statistics in Medicine|April 6, 2006
A method for therapeutic dose selection in a phase II clinical trial using contrast statisticsAkira Wakana, Isao Yoshimura, Chikuma HamadaInternational Journal of Clinical Oncology|September 18, 2024
Pembrolizumab in Japanese patients with primary mediastinal large B-cell lymphoma: results from the KEYNOTE-A33 studyKoji Kato, Sosuke Nakamura, Akira Wakana, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 10, 2015
Evaluation of the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin in healthy Japanese subjectsIkuo Aoki, Kensuke Ishikawa, Akira Wakana, et al.Human Vaccines & Immunotherapeutics|February 12, 2020
A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician's attitudeAtsushi Nakamura, Kenji Kawakami, Akira Wakana, et al.Human Vaccines & Immunotherapeutics|December 5, 2019
A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and olderKenji Kawakami, Atsushi Nakamura, Akira Wakana, et al.Japanese Journal of Infectious Diseases|December 23, 2016
Safety and Immunogenicity of a 9-Valent Human Papillomavirus Vaccine Administered to 9- to 15-Year-Old Japanese GirlsSatoshi Iwata, Shinya Murata, Shi Rong Han, et al.Journal of Diabetes Investigation|May 17, 2016
Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese menSaori Tsuchiya, Evan Friedman, Carol Addy, et al.Vaccine|February 25, 2019
Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled studyHiroshige Mikamo, Yuka Yamagishi, Shinya Murata, et al.Diabetes, Obesity & Metabolism|May 18, 2018
Effect of short-term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug-naïve Japanese patients with type 2 diabetes mellitusRyo Suzuki, Jun-Ichi Eiki, Takashi Moritoyo, et al.Therapeutic Innovation & Regulatory Science|September 21, 2018
Current Practice on Multiplicity Adjustment and Sample Size Calculation in Multi-arm Clinical Trials: An Industry Survey in JapanKentaro Sakamaki, Toshifumi Kamiura, Yusuke Morita, et al.Pageof 2